Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
Google ScholarÂ
Pare A, Joly A. [Oral cancer: risk factors and management]. Presse Med. 2017;46:320–30.
Google ScholarÂ
Mello FW, Melo G, Pasetto JJ, Silva CAB, Warnakulasuriya S, Rivero ERC. The synergistic effect of tobacco and alcohol consumption on oral squamous cell carcinoma: a systematic review and meta-analysis. Clin Oral Investig. 2019;23:2849–59.
Google ScholarÂ
Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsague X, Laporte L, et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15:1319–31.
Google ScholarÂ
Majitha CS, Nayak DR, Shetty S, Devaraja K, Basheer JI. Distant metastasis at the time of presentation of head and neck squamous cell carcinoma: a retrospective chart review from a tertiary cancer care centre. J Laryngol Otol. 2024;138:661–6.
Google ScholarÂ
Xu C, Zhang J, Zhang H, Chen L, Zhao J, Yang G, et al. HOMER3 drives oral squamous cell carcinoma progression through TRPV6 calcium influx and TUBB3 microtubule stabilization. Oncogene. 2026;45:278–94.
Google ScholarÂ
Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology, and characterization of circular RNAs. Nat Rev Genet. 2019;20:675–91.
Google ScholarÂ
Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32:453–61.
Google ScholarÂ
Szabo L, Salzman J. Detecting circular RNAs: bioinformatic and experimental challenges. Nat Rev Genet. 2016;17:679–92.
Google ScholarÂ
Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z, Sharpless NE. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet. 2010;6:e1001233.
Google ScholarÂ
Hansen TB, Wiklund ED, Bramsen JB, Villadsen SB, Statham AL, Clark SJ, et al. miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO J. 2011;30:4414–22.
Google ScholarÂ
Li S, Kang Y, Guan Y, Li J, Jiang R, Zhang S, et al. Specifically targeted engineered exosomes loaded with circAKR1A1 enhance tumorigenesis and metastasis in prostate cancer by activating the PI3K/Akt signalling pathway. Oncogene. 2026;45:2596–610.
Google ScholarÂ
Yi Q, Feng J, Lan W, Shi H, Sun W, Sun W. CircRNA and lncRNA-encoded peptides in diseases, an update review. Mol Cancer. 2024;23:214.
Google ScholarÂ
Liu C, Chen L. Circular RNAs: Characterization, cellular roles, and applications. Cell. 2022;185:2016–34.
Google ScholarÂ
Wang Y, Li Y, Toth JI, Petroski MD, Zhang Z, Zhao JC. N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells. Nat Cell Biol. 2014;16:191–8.
Google ScholarÂ
Bokar JA, Shambaugh ME, Polayes D, Matera AG, Rottman FM. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA. 1997;3:1233–47.
Google ScholarÂ
Fu Y, Dominissini D, Rechavi G, He C. Gene expression regulation mediated through reversible m(6)A RNA methylation. Nat Rev Genet. 2014;15:293–306.
Google ScholarÂ
Niu X, Yang Y, Ren Y, Zhou S, Mao Q, Wang Y. Crosstalk between m(6)A regulators and mRNA during cancer progression. Oncogene. 2022;41:4407–19.
Google ScholarÂ
Piperi C, Markouli M, Gargalionis AN, Papavassiliou KA, Papavassiliou AG. Deciphering glioma epitranscriptome: focus on RNA modifications. Oncogene. 2023;42:2197–206.
Google ScholarÂ
Vu LP, Cheng Y, Kharas MG. The biology of m(6)A RNA methylation in normal and malignant hematopoiesis. Cancer Discov. 2019;9:25–33.
Google ScholarÂ
Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.
Google ScholarÂ
Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62:335–45.
Google ScholarÂ
He X, Li Y, Li J, Li Y, Chen S, Yan X, et al. HDAC2-mediated METTL3 delactylation promotes DNA damage repair and chemotherapy resistance in triple-negative breast cancer. Adv Sci. 2025;12:e2413121.
Google ScholarÂ
Chen Z, Zhou Y, Xue C, Zeng L, Deng S, Xu Z, et al. Psychological stress-induced ALKBH5 deficiency promotes tumour innervation and pancreatic cancer via extracellular vesicle transfer of RNA. Nat Cell Biol. 2025;27:1035–47.
Google ScholarÂ
Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, et al. FTO plays an oncogenic role in acute myeloid leukemia as an N(6)-methyladenosine RNA demethylase. Cancer Cell. 2017;31:127–41.
Google ScholarÂ
Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, et al. The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol. 2019;12:121.
Google ScholarÂ
Yi Q, Liao Y, Sun W, Li J, Yang D, Shang H, et al. m6A modification of non‑coding RNA: mechanisms, functions and potential values in human diseases (Review). Int J Mol Med. 2025;56:164.
Google ScholarÂ
Qiu X, Ke X, Ma H, Han L, Chen Q, Zhang S, et al. Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing. J Cell Biochem. 2019;120:4102–12.
Google ScholarÂ
Yu D, Pan M, Li Y, Lu T, Wang Z, Liu C, et al. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. J Exp Clin Cancer Res. 2022;41:6.
Google ScholarÂ
Weng H, Huang F, Yu Z, Chen Z, Prince E, Kang Y, et al. The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell. 2022;40:1566–1582.e10.
Google ScholarÂ
Lu W, Yang X, Zhong W, Chen G, Guo X, Ye Q, et al. METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2. J Clin Investig. 2024;134:e174847.
Google ScholarÂ
Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44:e91.
Google ScholarÂ
Yuan S, Zhang P, Wen L, Jia S, Wu Y, Zhang Z, et al. miR-22 promotes stem cell traits via activating Wnt/beta-catenin signaling in cutaneous squamous cell carcinoma. Oncogene. 2021;40:5799–813.
Google ScholarÂ
Tang Y, Shen J, Zhang F, Yang FY, Liu M. Human serum albumin attenuates global cerebral ischemia/reperfusion-induced brain injury in a Wnt/beta-Catenin/ROS signaling-dependent manner in rats. Biomed Pharmacother. 2019;115:108871.
Google ScholarÂ
Kikuchi A, Matsumoto S, Sada R. Dickkopf signaling, beyond Wnt-mediated biology. Semin Cell Dev Biol. 2022;125:55–65.
Google ScholarÂ
Xu Y, Hu J, Lv Q, Shi C, Qiu M, Xie L, et al. Endometrium-derived mesenchymal stem cells suppress progression of endometrial cancer via the DKK1-Wnt/beta-catenin signaling pathway. Stem Cell Res Ther. 2023;14:159.
Google ScholarÂ
Wang J, Li Q, Liang F, Du X, Song P, Wu T, et al. Dickkopf-1 drives perineural invasion via the PI3K-AKT signaling pathway in head and neck squamous cancer. MedComm. 2024;5:e518.
Google ScholarÂ
Luo M, Chen YJ, Xie Y, Wang QR, Xiang YN, Long NY, et al. Dickkopf-related protein 1/cytoskeleton-associated protein 4 signaling activation by Helicobacter pylori-induced activator protein-1 promotes gastric tumorigenesis via the PI3K/AKT/mTOR pathway. World J Gastroenterol. 2022;28:6769–87.
Google ScholarÂ
Kimura H, Yamamoto H, Harada T, Fumoto K, Osugi Y, Sada R, et al. CKAP4, a DKK1 receptor, is a biomarker in exosomes derived from pancreatic cancer and a molecular target for therapy. Clin Cancer Res. 2019;25:1936–47.
Google ScholarÂ
Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21:475–90.
Google ScholarÂ
Kristensen LS, Hansen TB, Veno MT, Kjems J. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37:555–65.
Google ScholarÂ
Mo Y, Wang Y, Zhang S, Xiong F, Yan Q, Jiang X, et al. Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2. Mol Cancer. 2021;20:112.
Google ScholarÂ
Mo Y, Wang Y, Wang Y, Deng X, Yan Q, Fan C, et al. Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the beta-TrCP/c-Myc/SRSF1 positive feedback loop. Mol Cancer. 2022;21:192.
Google ScholarÂ
Ramesh-Kumar D, Guil S. The IGF2BP family of RNA- binding proteins links epitranscriptomics to cancer. Semin Cancer Biol. 2022;86:18–31.
Google ScholarÂ
Cai J, Chen Z, Zhang Y, Wang J, Zhang Z, Wu J, et al. CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m(6)A modification in hepatocellular carcinoma. Mol Ther Oncolytics. 2022;24:755–71.
Google ScholarÂ
Li Y, Wang Z, Gao P, Cao D, Dong R, Zhu M, et al. CircRHBDD1 promotes immune escape via IGF2BP2/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. J Transl Med. 2024;22:704.
Google ScholarÂ
Long F, Zhong C, Long Q, Zhu K, Wang J, Yu Y, et al. Circular RNA RHBDD1 regulates tumorigenicity and ferroptosis in colorectal cancer by mediating the ELAVL1/SCD mRNA interaction. Cancer Gene Ther. 2024;31:237–49.
Google ScholarÂ
Zhou WY, Cai ZR, Liu J, Wang DS, Ju HQ, Xu RH. Circular RNA: metabolism, functions, and interactions with proteins. Mol Cancer. 2020;19:172.
Google ScholarÂ
He RZ, Jiang J, Luo DX. M6A modification of circNSUN2 promotes colorectal liver metastasis. Genes Dis. 2021;8:6–7.
Google ScholarÂ
Zhai J, Chen H, Wong CC, Peng Y, Gou H, Zhang J, et al. ALKBH5 drives immune suppression via targeting AXIN2 to promote colorectal cancer and is a target for boosting immunotherapy. Gastroenterology. 2023;165:445–62.
Google ScholarÂ
Kimura H, Fumoto K, Shojima K, Nojima S, Osugi Y, Tomihara H, et al. CKAP4 is a Dickkopf1 receptor and is involved in tumor progression. J Clin Invest. 2016;126:2689–705.
Google ScholarÂ
Wei Y, Long S, Zhao M, Zhao J, Zhang Y, He W, et al. Regulation of cellular signaling with an aptamer inhibitor to impede cancer metastasis. J Am Chem Soc. 2024;146:319–29.
Google ScholarÂ
Jaschke N, Hofbauer LC, Gobel A, Rachner TD. Evolving functions of Dickkopf-1 in cancer and immunity. Cancer Lett. 2020;482:1–7.
Google ScholarÂ
Ye X, Liu J, Quan R, Lu Y, Zhang J. DKK1 affects survival of patients with head and neck squamous cell carcinoma by inducing resistance to radiotherapy and immunotherapy. Radiother Oncol. 2023;181:109485.
Google ScholarÂ

